Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19
Clinical trial NCT04590222 · COMPLETED
Trial details
- NCT number
- NCT04590222
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-20
- Primary completion
- 2022-01-19
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.